Advocates fear New York state could be taking a step back when it comes to biomarker testing access for those with Medicaid.

Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

A group of cancer survivors from the Bronx and statewide gathered outside Gov. Kathy Hochul’s NYC office on Third Avenue on ...

Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove ...

Precision medicine relies on biomarker testing to match therapies to specific cancers, yet many patients remain untested due to standardization issues. Recommendations include educating clinicians, ...

Every year, America’s medical research pipeline produces new treatments, new technologies and new ways to improve patient care. Often, the real challenge is ensuring policy keeps pace with these ...

A blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, predicted a faster buildup of ...

It’s common to wait until something feels “off” before making an appointment to see a healthcare provider. But waiting for noticeable symptoms can mean missing the chance to catch health issues early.